1. Home
  2. VREX vs AHRT Comparison

VREX vs AHRT Comparison

Compare VREX & AHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$10.77

Market Cap

580.6M

Sector

Technology

ML Signal

HOLD

AHRT

AH Realty Trust Inc. Common Stock

N/A

Current Price

$5.14

Market Cap

498.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VREX
AHRT
Founded
2016
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Real Estate
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
580.6M
498.7M
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
VREX
AHRT
Price
$10.77
$5.14
Analyst Decision
Strong Buy
Hold
Analyst Count
3
1
Target Price
$16.67
$7.00
AVG Volume (30 Days)
248.4K
1.9M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
10.51%
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$811,000,000.00
N/A
Revenue This Year
$5.35
$840.79
Revenue Next Year
$3.88
$10.97
P/E Ratio
$215.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.76
$5.30
52 Week High
$14.57
$6.11

Technical Indicators

Market Signals
Indicator
VREX
AHRT
Relative Strength Index (RSI) 32.50 28.97
Support Level $9.81 N/A
Resistance Level $12.61 $5.98
Average True Range (ATR) 0.37 0.24
MACD 0.01 -0.06
Stochastic Oscillator 33.47 2.56

Price Performance

Historical Comparison
VREX
AHRT

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

Share on Social Networks: